Ronald E. Osman - 18 Aug 2023 Form 4 Insider Report for Inhibitor Therapeutics, Inc. (INTI)

Role
Director, 10%+ Owner
Signature
/s/ Ronald E. Osman
Issuer symbol
INTI
Transactions as of
18 Aug 2023
Net transactions value
$0
Form type
4
Filing time
29 Aug 2023, 15:49:19 UTC
Next filing
16 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INTI Common Stock Award $0 +25,000 +0.11% $0.000000 23,514,985 11 Aug 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant from the company for no consideration
F2 These shares represent 25,000 shares owned by Mr. Osman and remaining number of shares of common stock held by The Ronald E. Osman Trust III. Mr. Osman is the sole trustee of the Ronald E. Osman Trust III.

Remarks:

Chief Executive Officer, Executive Chairman of the Board